“Do you know any other part of
health insurance where premiums have not just remained stable, but [actually]
decreased? And the premium is what reflects the plan’s liability. The costs in
the program are going up, but the premiums remain the same, so who’s paying the
difference?”
— Sean
Creighton, a vice president at Avalere, talked with AIS’s Radar on Drug Benefits about the impact of cost-shifting caused by Part D’s notorious
“doughnut hole.”
No comments:
Post a Comment